Cencora (ABG) Stock Forecast & Price Target

Compare

1 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

ABG Analyst Ratings

Strong Buy

9 Buy

3 Hold

0 Sell

Based on 12 analysts giving stock ratings to

Cencora

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

ABG Stock 12 Month Forecast

Average Price Target

€282.34

▲(15.43%Upside)

Based on 12 Wall Street analysts offering 12 month price targets for Cencora in the last 3 months. The average price target is €282.34 with a high forecast of €301.90 and a low forecast of €255.12. The average price target represents a 15.43% change from the last price of €244.60.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"197":"€197","302":"€302","223.25":"€223.3","249.5":"€249.5","275.75":"€275.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":301.8956494,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€301.90</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":282.33621296,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€282.34</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":255.123084,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€255.12</span>\n  </div></div>","useHTML":true}}],"tickPositions":[197,223.25,249.5,275.75,302],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2024","6":"Dec<br/>2024","9":"Mar<br/>2025","12":"Jun<br/>2025","25":"Jun<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,252.3,256.11504995384615,259.9300999076923,263.7451498615385,267.56019981538464,271.3752497692308,275.1902997230769,279.0053496769231,282.82039963076926,286.6354495846154,290.45049953846154,294.26554949230774,298.0805994461539,{"y":301.8956494,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,252.3,254.61047792000002,256.92095584000003,259.23143376,261.54191168,263.85238960000004,266.16286752,268.47334544,270.78382336,273.09430128,275.4047792,277.71525712,280.02573504000003,{"y":282.33621296,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,252.3,252.5171603076923,252.73432061538463,252.95148092307693,253.16864123076925,253.38580153846155,253.60296184615385,253.82012215384617,254.03728246153847,254.25444276923076,254.4716030769231,254.68876338461538,254.9059236923077,{"y":255.123084,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":200.109,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":205.859,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":215.872,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":213.107,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":198.621,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":206.401,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":235.389,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":213.881,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":245.595,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":236.723,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":253.59,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":253.54,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":252.3,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target€301.90

Average Price Target€282.34

Lowest Price Target€255.12

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Steven ValiquetteMizuho Securities

Mizuho Securities

€269.64

Buy

10.24%

Upside

Reiterated

06/27/25

Cencora (COR) Receives a Buy from Mizuho Securities

Stephen BaxterWells Fargo

Wells Fargo

€233.81→€287.56

Buy

17.56%

Upside

Upgraded

06/03/25

Cencora upgraded to Overweight from Equal Weight at Wells FargoCencora upgraded to Overweight from Equal Weight at Wells Fargo

Eric ColdwellRobert W. Baird

Robert W. Baird

€298.66→€299.51

Buy

22.45%

Upside

Reiterated

05/28/25

Cencora (COR) Receives a Buy from Robert W. Baird

Lisa GillJ.P. Morgan

J.P. Morgan

€278.18

Buy

13.73%

Upside

Reiterated

05/12/25

Analysts Offer Insights on Healthcare Companies: Cencora (NYSE: COR), Sionna Therapeutics, Inc. (NASDAQ: SION) and Astria Therapeutics (NASDAQ: ATXS)

Erin WrightMorgan Stanley

Morgan Stanley

€245.75→€267.08

Hold

9.19%

Upside

Reiterated

05/08/25

Cencora's Mixed Performance: Strong U.S. Growth Offset by International Challenges and Strategic Caution

Daniel GrosslightCiti

Citi

€281.59→€302.92

Buy

23.84%

Upside

Reiterated

05/08/25

Cencora price target raised to $355 from $330 at CitiCencora price target raised to $355 from $330 at Citi

Michael ChernyLeerink Partners

Leerink Partners

€270.5→€297.8

Buy

21.75%

Upside

Reiterated

05/07/25

Analysts' Opinions Are Mixed on These Healthcare Stocks: Design Therapeutics (NASDAQ: DSGN), Zoetis (NYSE: ZTS) and Cencora (NYSE: COR)

Charles RhyeeTD Cowen

TD Cowen

€285.86→€298.66

Buy

22.10%

Upside

Reiterated

05/07/25

Cencora's Strong U.S. Performance and Growth Prospects Justify Buy Rating

Elizabeth Anderson CFAEvercore ISI

Evercore ISI

€273.06

Buy

11.63%

Upside

Reiterated

05/07/25

Evercore ISI Keeps Their Buy Rating on Cencora (COR)

Kevin CaliendoUBS

UBS

€254.28→€285.86

Buy

16.87%

Upside

Reiterated

04/29/25

Cencora price target raised to $335 from $298 at UBSCencora price target raised to $335 from $298 at UBS

Allen LutzBank of America Securities

Bank of America Securities

―

Hold

―

Reiterated

04/15/25

Analysts Conflicted on These Healthcare Names: Cencora (NYSE: COR) and Johnson & Johnson (NYSE: JNJ)

David ToungArgus Research

Argus Research

€230.39→€238.93

Buy

-2.32%

Downside

Reiterated

02/28/25

Cencora price target raised to $280 from $270 at ArgusCencora price target raised to $280 from $270 at Argus

Brian TanquilutJefferies

Jefferies

€213.33→€234.66

Hold

-4.06%

Downside

Reiterated

02/05/25

Cencora Inc (COR) PT Raised to $275 at JefferiesJefferies analyst Brian Tanquilut raised the price target on Cencora Inc (NYSE: COR) to $275.00 (from $250.00) while maintaining a Hold rating.

Stephanie DavisBarclays

Barclays

€224.42→€247.46

Buy

1.17%

Upside

Reiterated

11/07/24

Analysts' Top Healthcare Picks: CVS Health (CVS), Revolution Medicines (RVMD)

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Steven ValiquetteMizuho Securities

Mizuho Securities

€269.64

Buy

10.24%

Upside

Reiterated

06/27/25

Cencora (COR) Receives a Buy from Mizuho Securities

Stephen BaxterWells Fargo

Wells Fargo

€233.81→€287.56

Buy

17.56%

Upside

Upgraded

06/03/25

Cencora upgraded to Overweight from Equal Weight at Wells FargoCencora upgraded to Overweight from Equal Weight at Wells Fargo

Eric ColdwellRobert W. Baird

Robert W. Baird

€298.66→€299.51

Buy

22.45%

Upside

Reiterated

05/28/25

Cencora (COR) Receives a Buy from Robert W. Baird

Lisa GillJ.P. Morgan

J.P. Morgan

€278.18

Buy

13.73%

Upside

Reiterated

05/12/25

Analysts Offer Insights on Healthcare Companies: Cencora (NYSE: COR), Sionna Therapeutics, Inc. (NASDAQ: SION) and Astria Therapeutics (NASDAQ: ATXS)

Erin WrightMorgan Stanley

Morgan Stanley

€245.75→€267.08

Hold

9.19%

Upside

Reiterated

05/08/25

Cencora's Mixed Performance: Strong U.S. Growth Offset by International Challenges and Strategic Caution

Daniel GrosslightCiti

Citi

€281.59→€302.92

Buy

23.84%

Upside

Reiterated

05/08/25

Cencora price target raised to $355 from $330 at CitiCencora price target raised to $355 from $330 at Citi

Michael ChernyLeerink Partners

Leerink Partners

€270.5→€297.8

Buy

21.75%

Upside

Reiterated

05/07/25

Analysts' Opinions Are Mixed on These Healthcare Stocks: Design Therapeutics (NASDAQ: DSGN), Zoetis (NYSE: ZTS) and Cencora (NYSE: COR)

Charles RhyeeTD Cowen

TD Cowen

€285.86→€298.66

Buy

22.10%

Upside

Reiterated

05/07/25

Cencora's Strong U.S. Performance and Growth Prospects Justify Buy Rating

Elizabeth Anderson CFAEvercore ISI

Evercore ISI

€273.06

Buy

11.63%

Upside

Reiterated

05/07/25

Evercore ISI Keeps Their Buy Rating on Cencora (COR)

Kevin CaliendoUBS

UBS

€254.28→€285.86

Buy

16.87%

Upside

Reiterated

04/29/25

Cencora price target raised to $335 from $298 at UBSCencora price target raised to $335 from $298 at UBS

Allen LutzBank of America Securities

Bank of America Securities

―

Hold

―

Reiterated

04/15/25

Analysts Conflicted on These Healthcare Names: Cencora (NYSE: COR) and Johnson & Johnson (NYSE: JNJ)

David ToungArgus Research

Argus Research

€230.39→€238.93

Buy

-2.32%

Downside

Reiterated

02/28/25

Cencora price target raised to $280 from $270 at ArgusCencora price target raised to $280 from $270 at Argus

Brian TanquilutJefferies

Jefferies

€213.33→€234.66

Hold

-4.06%

Downside

Reiterated

02/05/25

Cencora Inc (COR) PT Raised to $275 at JefferiesJefferies analyst Brian Tanquilut raised the price target on Cencora Inc (NYSE: COR) to $275.00 (from $250.00) while maintaining a Hold rating.

Stephanie DavisBarclays

Barclays

€224.42→€247.46

Buy

1.17%

Upside

Reiterated

11/07/24

Analysts' Top Healthcare Picks: CVS Health (CVS), Revolution Medicines (RVMD)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Cencora

1 Month

xxx

Success Rate

11/19 ratings generated profit

Average Return

+3.19%

reiterated a xxx

rating 2 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 57.89% of your transactions generating a profit, with an average return of +3.19% per trade.

3 Months

xxx

Success Rate

25/35 ratings generated profit

Average Return

+5.91%

reiterated a xxx

rating 2 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 71.43% of your transactions generating a profit, with an average return of +5.91% per trade.

1 Year

Eric ColdwellRobert W. Baird

Success Rate

41/43 ratings generated profit

Average Return

+22.83%

reiterated a buy rating last month

Copying Eric Coldwell's trades and holding each position for 1 Year would result in 95.35% of your transactions generating a profit, with an average return of +22.83% per trade.

2 Years

xxx

Success Rate

41/43 ratings generated profit

Average Return

+44.82%

reiterated a xxx

rating last month

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 95.35% of your transactions generating a profit, with an average return of +44.82% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ABG Analyst Recommendation Trends

Rating

Feb 25

Mar 25

Apr 25

May 25

Jun 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, ABG has received 17 Buy Ratings, 4 Hold Ratings, and 0 Sell Ratings. ABG average Analyst price target in the past 3 months is 282.34.

Each month's total comprises the sum of three months' worth of ratings.

ABG Financial Forecast

ABG Earnings Forecast

Next quarter’s earnings estimate for ABG is €3.25 with a range of €3.10 to €3.38. The previous quarter’s EPS was €3.75. ABG beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 45.45% of the time in the same period. In the last calendar year ABG has Outperformed its overall industry.

ABG Sales Forecast

Next quarter’s sales forecast for ABG is €68.23B with a range of €66.68B to €70.04B. The previous quarter’s sales results were €64.06B. ABG beat its sales estimates 75.00% of the time in past 12 months, while its overall industry beat sales estimates 57.81% of the time in the same period. In the last calendar year ABG has Outperformed its overall industry.

ABG Stock Forecast FAQ

What is DE:ABG’s average 12-month price target, according to analysts?

Based on analyst ratings, Cencora’s 12-month average price target is 282.34.

What is DE:ABG’s upside potential, based on the analysts’ average price target?

Cencora has 15.43% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Cencora a Buy, Sell or Hold?

Cencora has a consensus rating of Strong Buy, which is based on 9 buy ratings, 3 hold ratings and 0 sell ratings.

What is Cencora’s share price target?

The average share price target for Cencora is 282.34. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €301.90 ,and the lowest forecast is €255.12. The average share price target represents 15.43% Increase from the current price of €244.6.

What do analysts say about Cencora?

Cencora’s analyst rating consensus is a Strong Buy. This is based on the ratings of 12 Wall Streets Analysts.

How can I buy shares of Cencora?

To buy shares of DE:ABG, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Cencora (ABG) Stock Forecast & Price Target

ABG Analyst Ratings

ABG Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Cencora

ABG Analyst Recommendation Trends

ABG Financial Forecast

ABG Earnings Forecast

ABG Sales Forecast

ABG Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts